BEDIER, H. et al. Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19. European Journal of Case Reports in Internal Medicine, v. 10, n. 12, 17 Nov.2023.